During the BIO-Europe conference in Stockholm, Optimum co-hosted a special reception featuring a fireside chat with Renée Aguiar-Lucander, former CEO of Calliditas, who led the Swedish company since 2017 until recently – taking it from small biotech to its $1.1 billion acquisition. Here, we tell the story of her remarkable seven-year journey with the firm. Novo […]
When and Where 📍 4th December, 1 Wimpole Street, London Genesis 2024 is a fantastic opportunity for our ecosystem to connect, collaborate, and create returns for innovators, investors, patients, and society. The Optimum team will be in attendance, so if you would like to meet with us please do reach out. If you register with […]
During the BIO-Europe conference in Stockholm, Optimum co-hosted a special reception featuring a fireside chat with Renée Aguiar-Lucander, former CEO of Calliditas, who led the Swedish company since 2017 until recently – taking it from small biotech to its $1.1 billion acquisition. Here, we tell the story of her remarkable seven-year journey with the firm. […]
By Richard Staines, Optimum Strategic Communications The re-election of Donald Trump as President of the Unites States represents a seismic shift in the U.S. political system, with huge ramifications for all policy areas including healthcare. But, at the time of writing, the identity of the next Secretary of the Department of Health and Human Services […]
Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, on Friday announced that it will be presenting three posters on its pioneering cancer vaccine discovery and development, including one that has been recognised as a ‘top 100’ poster presentation, at the Society […]
